Analysis of tumor cells explanted at the time of sacrifice revealed an 80-85% reduction in Abl and Arg proteins (Figure S1), which was similar to what we observed in ABL and ARG KD cells prior to implantation (Figure 1D), demonstrating that ABL and ARG knockdown was maintained in tumor cells in vivo. The gene discussed is ABL1; the disease is neoplasm.